Table 2.
Clinically normal range | Clinically abnormal range | |||
---|---|---|---|---|
zFEV1 ≥0 | zFEV1 <0 to -1 | zFEV1 <-1 to -2 | zFEV1 <-2 | |
n (%) | ||||
Deceased | ||||
First Nations | 0/97 (0%) | 9/200 (5%) | 20/319 (6%) | 77/497 (15%) |
Non-First Nations | 1/76 (1%) | 5/125 (5%) | 12/150 (8%) | 64/269 (24%) |
Respiratory disease | ||||
First Nations | 33/97 (34%) | 134/200 (67%) | 242/319 (76%) | 427/497 (86%) |
Non-First Nations | 40/76 (54%) | 84/126 (67%) | 118/150 (79%) | 236/269 (88%) |
Cardiovascular disease | ||||
First Nations | 10/97 (10%) | 26/200 (13%) | 69/319 (22%) | 133/497 (27%) |
Non-First Nations | 9/76 (12%) | 22/126 (17%) | 27/150 (18%) | 85/269 (32%) |